The Medical Imaging & Technology Alliance (MITA) has formed a partnership with the Focused Ultrasound Foundation to raise awareness of focused ultrasound technology among policymakers, payers, and medical specialty societies.
“Recent developments in the field of focused ultrasound, deploying image-guided innovative technology, are demonstrating the potential of this innovative technology to help treat a range of clinical conditions including cancer and functional disorders of the brain,” says Patrick Hope, executive director of MITA. “The Focused Ultrasound Foundation partnership will strengthen our Working Group’s voice as we further inform legislators on this cost effective method of treatment, advocate for reimbursement by public and private payers, and encourage incorporation of the technology into clinical guidelines.”
“This partnership is an important step for the biomedical community in breaking down the silos that impede progress,” says Mark Carol, chief executive officer and president of Sonacare and chairman of MITA’s Focused Ultrasound Working Group. “Our work together will help create a culture of collaboration that will benefit patients, providers, and manufacturers by accelerating the acceptance and adoption of therapeutic focused ultrasound.”
“The Foundation’s partnership with MITA will enable us to demonstrate the enormous potential of focused ultrasound to a wider group of decision makers,” says Jessica Foley, chief scientific officer of Focused Ultrasound Foundation. “Our Working Group is eager to advocate for common goals related to commercialization and advance the field towards clinical adoption.”
Focused ultrasound is an early-stage noninvasive therapeutic technology that has the potential to transform the management of a variety of serious medical disorders. It is shown to be a cost-effective alternative or complement to surgery, radiation therapy, chemotherapy, and immunotherapy for many clinical conditions.
